Wedbush Starts Surface Oncology (SURF) at Outperform
Tweet
Share
E-mailGet Alerts SURF Hot Sheet
Price: $1.07 --0%
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
4 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Wedbush analyst Robert Driscoll initiates coverage on Surface Oncology (NASDAQ: SURF) with a Outperform rating and a price target of $12.00.
For an analyst ratings summary and ratings history on Surface Oncology click here. For more ratings news on Surface Oncology click here.
Shares of Surface Oncology closed at $5.46 yesterday.
You May Also Be Interested In
- Raymond James Starts SpyGlass Pharma (SGP) at Outperform
- Seaport Global Securities Starts ADI Global Distribution (ADIG) at Buy
- Leerink Starts Ligand Pharma (LGND) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
